Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID‐19

OBJECTIVES: Coronavirus disease 2019 (COVID‐19) is rapidly spreading worldwide. Lianhua Qingwen capsule (LQC) has shown therapeutic effects in patients with COVID‐19. This study is aimed to discover its molecular mechanism and provide potential drug targets. MATERIALS AND METHODS: An LQC target and...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Qi‐Dong, Xun, Yang, Lu, Jun‐Lin, Lu, Yu‐Chao, Yang, Yuan‐Yuan, Zhou, Peng, Hu, Jia, Li, Cong, Wang, Shao‐Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Manuscripts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705900/
https://www.ncbi.nlm.nih.gov/pubmed/33140889
http://dx.doi.org/10.1111/cpr.12949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705900/
https://www.ncbi.nlm.nih.gov/pubmed/33140889
http://dx.doi.org/10.1111/cpr.12949

Ejemplares similares